Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Aytu Biopharma (AYTU) Leases (2019 - 2025)

Aytu Biopharma (AYTU) has disclosed Leases for 7 consecutive years, with $959000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Leases fell 18.59% to $959000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $959000.0, a 18.59% decrease, with the full-year FY2025 number at $1.1 million, up 27.99% from a year prior.
  • Leases was $959000.0 for Q4 2025 at Aytu Biopharma, down from $1.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $3.8 million in Q4 2021 to a low of $159000.0 in Q2 2023.
  • A 5-year average of $1.8 million and a median of $1.2 million in 2024 define the central range for Leases.
  • Peak YoY movement for Leases: soared 1138.41% in 2021, then tumbled 95.14% in 2023.
  • Aytu Biopharma's Leases stood at $3.8 million in 2021, then plummeted by 30.43% to $2.7 million in 2022, then dropped by 20.26% to $2.1 million in 2023, then plummeted by 44.77% to $1.2 million in 2024, then decreased by 18.59% to $959000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Leases are $959000.0 (Q4 2025), $1.0 million (Q3 2025), and $1.1 million (Q2 2025).